Literature DB >> 6137858

Combined treatment of tardive dyskinesia with clonidine and neuroleptics: a follow-up study of three cases for three years.

T Nishikawa, M Tanaka, I Koga, Y Uchida.   

Abstract

Three cases of tardive dyskinesia with psychotic symptoms (one presenile psychosis; two schizophrenia) were successfully treated with both clonidine and neuroleptics for 3 years. The dyskinesia abolished or reduced by clonidine returned several months after discontinuation of clonidine. During the follow-up study, it was observed that combining neuroleptics with clonidine was superior to thioridazine, levomepromazine, or sulpiride for controlling the dyskinesia. These findings suggest that noradrenergic involvement is important in tardive dyskinesia and that other subtypes of dyskinesia might exist.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137858     DOI: 10.1007/bf00432124

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

2.  Differential effects of clonidine on alpha 1- and alpha 2-adrenoceptors in footshock-induced jumping behavior.

Authors:  T Nishikawa; M Tanaka; A Tsuda; Y Kohno; N Nagasaki
Journal:  Eur J Pharmacol       Date:  1983-04-08       Impact factor: 4.432

3.  Tourette's disorder and the use of clonidine.

Authors:  R C Ferre
Journal:  J Am Acad Child Psychiatry       Date:  1982-05

4.  Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients.

Authors:  D C Jimerson; R M Post; F J Stoddard; J C Gillin; W E Bunney
Journal:  Biol Psychiatry       Date:  1980-02       Impact factor: 13.382

5.  Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs.

Authors:  R Freedman; D Kirch; J Bell; L E Adler; M Pecevich; E Pachtman; P Denver
Journal:  Acta Psychiatr Scand       Date:  1982-01       Impact factor: 6.392

6.  Clonidine blocks acute opiate-withdrawal symptoms.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

7.  Enzyme studies in tardive dyskinesia. III. Noradrenergic hyperactivity in a subgroup of dyskinetic patients.

Authors:  D V Jeste; M Linnoila; C M Fordis; B H Phelps; R L Wagner; R J Wyatt
Journal:  J Clin Psychopharmacol       Date:  1982-10       Impact factor: 3.153

  7 in total
  2 in total

1.  Involvement of adenosine receptor activities in aggressive responses produced by clonidine in mice.

Authors:  I Ushijima; T Katsuragi; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Biphasic and long-lasting effect of ceruletide on tardive dyskinesia.

Authors:  T Nishikawa; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.